Lakshita Bhagtani transitioned from biotechnology to management studies at the University of Exeter, navigating the ...

Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced a planned leadership transition in its executive team. Howard ...

Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced a planned leadership transition in its executive team. After ...

Experienced senior executive brings proven track record in financial strategy, operational excellence, and commercial executionEMERYVILLE, Calif.--(BUSINESS WIRE)--#50kb--Ansa Biotechnologies Inc., ...

Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today shared first-in-human data from the ongoing inMMyCARTM study, a Phase 1 clinical trial ...

Moderna has hired veteran homeland security official David Parkin as its next Director of Threat Management, bringing a ...

Berlin’s refusal to address its dysfunctional power market comes at the cost of Europe’s entire electrical grid ...

The Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has approved 4201 new postgraduate ...

The 5th meeting of the Board of Studies of the Department of Natural and Basic Sciences at the University of Turbat (UoT) was held at UoT, under the chairmanship of Jahangir Khan Achakzai. The purpose ...

Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced that former Nimbus Therapeutics CEO, Jeb Keiper, has joined Strand's Board as an independent Director to ...

The MarketWatch News Department was not involved in the creation of this content. First data on Aptevo's new molecule presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting SEATTLE ...

Stephanie Schnittger, U.Va. Health chief financial officer, reported a positive financial performance for quarter one of ...